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The severity of illness in transplant patients and the
complexity of transplant operations results in signifi-
cant postoperative morbidity and mortality. Remark-
able efforts have been made by transplant physi-
cians to study and improve organ allocation, graft and
patient survival, immunosuppression and the long-
term management of post-transplant complications.
Less effort has been spent studying the actual trans-
plant operation and systems of acute transplant care.
The National Surgical Quality Improvement Program
(NSQIP) has provided a standardized approach to qual-
ity improvement and has demonstrated significant po-
tential for a reduction in postoperative morbidity and
mortality in other surgical disciplines. Medical cen-
ters are under increasing pressure to measure surgi-
cal quality and the nexus of transplant surgical quality
improvement should not lie in the hands of CMS or
JACHO, but rather it should be created and developed
within the transplant community. The time has come
for a national transplant surgical quality improvement
program based on the NSQIP infrastructure. Such a
proactive approach toward quality improvement from
the transplant community is an excellent investment
for patients, providers and health care payers.
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Introduction
Few health care disciplines are analyzed as rigorously as or-
gan transplantation in the United States. Based on massive
data collection efforts and state-of-the-art scientific analy-
sis, the Scientific Registry of Transplant Recipients (SRTR)
provides the analysis of national organ allocation and out-
comes data to the Organ Procurement and Transplantation
Network (OPTN). The OPTN develops policy for organ allo-
cation throughout the country, and significantly influences
national and international direction. Transplant physicians
and surgeons have pioneered these data systems, and can
be justifiably proud of the effort.
But the data systems as they exist should not be viewed as
a foundation for transplant quality improvement. They fo-
cus primarily on allocation of scarce resources, something
quite different. Because the standardized mechanisms for
reporting transplant complications do not exist, important
questions about transplant surgical quality remain unan-
swered. While the requirement for reporting of informa-
tion is already onerous, the reporting and collection of data
for quality improvement could be performed by the trans-
plant community by adopting a standardized approach to
quality improvement, using a quality reporting infrastruc-
ture based on the National Surgical Quality Improvement
Program (NSQIP). The NSQIP, now implemented in 128 VA
hospitals and an increasing number of private sector hos-
pitals, could be adapted to fit the transplant community
quality improvement needs. Such a system will likely be
an attractive investment for payers, since there are signif-
icant cost savings associated with a reduction in surgical
complications.
Our Quality Improvement System
Needs Improvement
What is currently missing, and what could be provided by
NSQIP, is an infrastructure, which would permit the com-
parative evaluation of surgical quality. The first step in a na-
tional quality infrastructure includes defining and standard-
izing comorbid conditions and postoperative complication
endpoints. An accurate (prospective) method for collect-
ing the data points must be established. When this is ac-
complished, a risk adjustment model can be devised and
tested. Finally, a workable model for auditing and testing
of inter-rater reliability is necessary. Using this standard-
ized approach, the national comparison of institutional sur-
gical quality becomes feasible. (Table 1) When variations
in risk-adjusted outcomes are identified, the “best prac-
tices” in the better performing hospitals can be identified
and disseminated. Using this approach, quality might be
improved. The VA hospital system saw a 27% reduction in
mortality and a 45% reduction in morbidity over the 10-year
interval that NSQIP was operational (1).
Patient and graft survival are standardized well in trans-
plant outcomes reporting. The glaring deficiency involves
666
Transplant Surgical Quality Program
Table 1: Five key elements to the success of the transplant NSQIP
(adapted from (1,4))
1. Concrete end points (short-term graft function, 30-day
survival, etc.)
2. Standardization of definitions and terms
3. Prospective data collection
4. Sophistication of the data collectors
5. Mechanism for risk adjustment
surgical complications. The rates of surgical complications
between institutions cannot be measured and compared
for the following reasons. First, the identification of post-
operative events is poor. In most institutions, identification
of complications is done retrospectively, and may even
use computerized administrative billing data sets. Billing
data does not distinguish comorbid conditions present at
the time of admission from complications occurring follow-
ing surgery. As a result, a ventilator-dependant liver trans-
plant candidate with pulmonary edema might mistakenly
be characterized by administrative data as having postoper-
ative pneumonia. In a recent study, data collected prospec-
tively by a trained nurse reviewer were compared to data
obtained in the same patients using an administrative data
set (2). Using the VA Patient Treatment File (PTF), a large
administrative data set, ICD-9CM codes for the preopera-
tive risk variables used in NSQIP were found in only 45%
of cases. Postoperative occurrences measured by NSQIP
data collectors were found in only 41% of the PTF reviews.
Sensitivity and positive predictive value of the administra-
tive data were poor, averaging 0.175 and 0.186, respec-
tively. Sensitivity and positive predictive value should be
≥0.90 to justify substituting ICD-9CM codes for prospec-
tive NSQIP evaluations done by nurse coordinators.
A second deficiency in transplant outcomes reporting
is the risk adjustment methodology. Risk adjustment is
poor because we have not fully identified, defined and
ranked comorbid conditions preoperatively, nor have we
defined the surgical complications of interest postopera-
tively and the interval at which they should be measured.
The center-specific reports (CSRs) from the SRTR provide
vast amounts of high quality risk-adjusted data focusing on:
mortality on the list, graft function and mortality following
transplant. Despite this, in the current system an obese,
alcoholic, smoker with a previous coronary artery bypass
grafting and a portocaval shunt has exactly the same risk
profile for liver transplant as a thin woman with primary
biliary cirrhosis and no other illnesses. In order to develop
a meaningful risk adjustment system, in this example, the
definition for “alcoholic” must be discussed and standard-
ized, likewise for “smoker,” “CABG,” “obese,” and “por-
tocaval shunt.” Similarly, surgical complications of interest
also need to be targeted and defined, and a measurement
end point, for example 30 days, decided upon. In the NSQIP
system a data definitions committee meets regularly and
rigorously defines variables. This attention to detail is diffi-
cult and time consuming, but essential to the process.
A final point is that the reliability of the data must be re-
peatedly confirmed. This is crucial because any quality re-
porting system will ultimately fail if participants lose faith
in the validity of the data. In the NSQIP system, nurse data
collectors are regularly tested for their understanding of
the definitions used, and each program is regularly audited
by an independent nurse team for accuracy. Few quality
improvement initiatives place this much emphasis on the
reliability of the data.
Success of NSQIP in the VA
and Private Sector
Significant improvements in the surgical care of veterans
have been made since the inception of the NSQIP. For ex-
ample, the Salt Lake City VAMC was noted to be a high
outlier for morbidity in general surgery related to postopera-
tive wound infections in 1996. The surgical group describes
how the feedback they received was used to critically as-
sess their care processes, determine root causes and de-
velopment care protocols to improve outcomes (3). Based
on NSQIP feedback, wound complication rates dropped
from 5.5% to 2.9%. The national data are also impressive.
Between the beginning of NSQIP data collection and 2002,
the 30-day mortality postoperative in the VA system has
decreased by 27% while the 30-day postoperative mor-
bidity rates have dropped by 45% (4). Most importantly,
the NSQIP has been accepted by regional VA surgical lead-
ers and administrators as a non-threatening, valid and con-
structive means to improve upon the surgical care of pa-
tients in the VA medical system.
The American College of Surgeons (ACS) has identified the
NSQIP as one of its priorities for American surgery. Led by
Tom Russell, the Executive Director of the ACS, and Scott
Jones, Director of Quality of Optimal Patient Care for the
ACS, the Board of Regents have supported a plan to ex-
pand the NSQIP, now called the ACS–NSQIP, to private
sector hospitals. Currently 80 hospitals, nationally, are fully
enrolled or in the process of enrollment. Many surgical spe-
cialties are considering the ACS–NSQIP structure for their
own quality initiatives.
Focus on System and not the Surgeon
We do not advocate that the transplant surgical quality im-
provement project function as a surgeon report card. The
compendium of site visits and studies performed by the
NSQIP have concluded that quality surgical care is primar-
ily a function of well-coordinated systems of care (4). In
addition, this initiative would be a peer-controlled program,
which will require the cooperation of transplant surgeons.
Directing the focus of the project at individual surgeon
outcomes would undoubtedly alienate the most important
participants in the project. We propose that no surgeon-
specific data be transmitted to the central database.
American Journal of Transplantation 2006; 6: 666–670 667
Englesbe et al.
Similarly, it may not be fair to compare a program that
does 300 transplants a year to a program that does 30.
Smaller programs are at significant risk for variable annual
outcomes. With the exception of a small steering com-
mittee, center anonymity must be assured. The success
of the initiative depends on the participation of a diverse
complement of centers. The surgeons participating in the
program must embrace the project as an opportunity to im-
prove the care of transplant patients in the United States
and elsewhere. If the program is viewed as a threat, it will
have less chance of success.
Financial Implications and Data Burden
The data burden and cost of reporting outcomes are sig-
nificant and currently lie heavily on the shoulders of the in-
dividual transplant centers. Per the Department of Health
and Human Services, the data submitted to the OPTN by
the OPOs and transplant hospitals is considered manda-
tory under 121.11(b) (2) of the “OPTN final rule.” Though
this reporting is burdensome and expensive, the transplant
community and our patients have greatly benefited from
the analysis of this data by UNOS and the SRTR and the
subsequent policy and practice changes.
Hospitals and medical centers also bear the burden of
massive amounts of data reporting (much of it regarding
“quality measures”) required by JCAHO (Joint Commis-
sion on Accreditation of Hospital Organizations) and CMS
(Center for Medicare Services). The nexus of transplant
surgical quality improvement should not lie in the hands of
CMS or JACHO; it should be created and developed within
the transplant community. Certainly most transplant physi-
cians would agree that the transplant community under-
stands the complexities of transplant care better than the
government.
Hospital administrators and insurance providers are well
aware of the high cost of surgical complications. In one
study, median hospital costs were lowest for patients
without complications (4487 dollars) compared with those
with minor (14 094 dollars) and major complications (28
356 dollars) (p < 0.001) (5). In the VA system, reduc-
tions in post-surgical pneumonias alone (exclusive of other
complications) have resulted in annual savings of $9.3
million (6,7). Improvements in post-operative morbidity
stand alone as sufficient benchmarks. Nonetheless, it
translates into reduced length of stay and increased pa-
tient satisfaction. Insurance carriers will look favorably
upon centers with a commitment to quality improve-
ment and cost reduction. In addition, participation in vol-
untary programs may reduce third party regulation and
oversight. Characterization of patient acuity and exem-
plary outcomes will provide leverage for transplant cen-
ter negotiations with hospital administration and insurance
companies.
In summary, efforts to improve transplant surgical quality
need to develop within the transplant community, or they
will likely be imposed in a less effective manner by third
parties. The cost of the program will be relatively small
compared to the potential benefits to our patients and sav-
ings to the payers.
Our Proposal
We propose a transplant NSQIP pilot program to start with
several transplant programs in the United States.
Step 1. Center Recruitment: We plan to recruit several
North American transplant centers to participate in a
pilot program (estimate approximately 3 to 5 centers).
Step 2. Data selection and standardization: Determination
of the variables and end points to be collected in the
Table 2: Data points for pilot liver transplant NSQIP
Demographics—age, sex, race, SS#, address, estimated annual
income, insurer type.
Surgical profile—etiology of liver failure, procedure, previous
abdominal surgery, TIPS, transplant number, admission status,
level/experience of surgeons in the OR, level/experience of
anesthesia in the OR.
Preoperative data—MELD, height, weight, DM, smoking,
functional status, hepatic (varices, amount of ascites, history
of SBP, etc.), renal (dialysis, creatinine 3 months ago,
creatinine at transplant, edema, etc.), pulmonary
(hepato-pulmonary syndrome, etc), neurologic (grade of
encephalopathy, etc.), cardiac (pulmonary HTN, previous MI,
etc.), nutrition (muscle wasting, etc.), body habitus (breadth of
rib margin, etc.) and lab values.
Donor data—age, height, weight, sex, preservation fluid/volume
of flush (HTK/UW), pressors, hemodynamic measures,
percent fat in liver (on biopsy), date admission to hospital,
date donation, cause of death, donor following cardiac death
technique, recovery times and lab values.
Intra-operative data—ASA, Mallampati, lines places, PA
pressures, OR times, fluids and transfusions, (serial measures
of MAP/PA pressures/coagulation profiles/blood gases), type
of incision made, bypass used, cava technique (piggyback,
bicaval, side to side), hepatic artery technique, portal vein
technique, revascularization times, bile duct technique,
drains/stents left in place, reperfusion hemodynamic data,
method of reperfusion, cardiac echo used, other infusions
used and intra-op occurrences.
Postoperative data—pressors, transfusion quantity in the ICU,
reoperations, hepatic (bile leak/stricture/location/management,
hepatic artery thrombosis/stenosis and management, caval
stenosis/management, primary non-function/relisting, portal
vein complications, recurrent ascites/management) respiratory
(date extubation, pneumonia, etc), renal (dialysis, creatinine
trends, diuresis), infectious (locations and organisms, sepsis,
antibiotics), neurologic (stroke, delirium, tacrolimus toxicity),
cardiac (myocardial infarction, arrhythmia, etc.), nutrition
(enteral nutrition started), immunosuppression regimen,
retransplant, death, discharge, functional status trends.
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Table 3: Data points for pilot kidney transplant NSQIP
Demographics—age, sex, race, SS#, address, estimated annual
income, insurer type.
Surgical profile—etiology of renal failure, previous surgery,
transplant number, level/experience of surgeons in the OR,
level/experience of anesthesia in the OR.
Preoperative data—height, weight, DM, smoking, functional
status, renal (dialysis, time on dialysis, type of dialysis, preop
urine output, etc.), hepatic (synthetic dysfunction), pulmonary
(COPD/steroids, etc.), vascular (PVOD, amputations, previous
revascularization), neurologic (previous stroke, etc.), cardiac
(ejection fraction, CAD, inducible ischemia, previous MI,
previous revascularization, etc.), nutrition (muscle wasting,
etc.) and lab values.
Donor data—height, weight, sex, race, right/left kidney,
preservation fluid/volume of flush (HTK/UW), living donor
(relationship, procurement technique, medical history),
deceased donor (pressors, hemodynamic measures, biopsy
results if applicable, date admission to hospital, date donation,
cause of death, donor following cardiac death technique,
expanded criteria donors, medical history), recovery times and
lab values.
Intra-operative data—ASA, Mallampati, lines places, OR times,
fluids and transfusions, serial measures of MAP and blood
gases, revascularization times, bladder anastomotic
technique, stent placed and reason, drains, reperfusion
hemodynamic data, diuretics used, immunosuppression, IVF
volume infused prior to reperfusion, mean intra-op blood
glucose, single/multiple artery/vein, side placed and intra-op
occurrences.
Postoperative data—ICU admission, immunosuppression (drugs
used, mean levels, calcineurin delay/induction), reoperations,
renal (dialysis/delayed graft function, creatinine trends,
diuresis volume, foley removal, stent removal, urinary leak,
stricture, infection and management), respiratory (date
extubation, pneumonia, etc.), endocrine (daily mean glucose),
infectious (locations and organisms, sepsis, antibiotics),
neurologic (stroke, delirium, tacrolimus toxicity), cardiac
(myocardial infarction, arrhythmia, etc.), death within 30 days,
technical graft loss, discharge date, functional status trends.
transplant NSQIP will be an arduous effort requiring the
cooperation of a variety of transplant physicians. Obvi-
ously, the clinical variables of interest will vary depend-
ing on patient age and failing organ. The data points
must focus on the system of care, not simply the trans-
plant operation. Medical, surgical, anesthetic and critical
care data points will be included. Potential data points
are detailed in Table 2 for liver transplantation, Table 3
for kidney transplantation and Table 4 for pancreas trans-
plantation. Depending on the expertise of the pilot cen-
ters, small bowel, lung and heart transplant data points
may be included.
Step 3. Hire a nurse reviewer: For a hospital or trans-
plant center to join, a nurse reviewer would be required.
These nurses must be highly qualified with significant
clinical experience. The nurses undergo a rigorous train-
ing period focusing on standardization of data definitions
and are subject to frequent audits to assure uniformity
of data collection standards and methods.
Table 4: Data points for pilot pancreas transplant NSQIP
Demographics—age, sex, race, SS#, address, estimated annual
income, insurer type.
Surgical profile—procedure (SPK, PAK, PTA), previous surgery,
transplant number, level/experience of surgeons in the OR,
level/experience of anesthesia in the OR.
Preoperative data—height, weight, DM duration, insulin dose,
smoking, functional status, endocrine (number/severity of
complications of DM, hypoglycemic unawareness,
admissions/ER visits for hypoglycemia), renal (dialysis, time
on dialysis, type of dialysis, preop urine output, etc.), hepatic
(synthetic dysfunction), pulmonary (COPD/steroids, etc.),
neurologic (previous stroke, etc.), vascular (PVOD,
amputations, previous revascularization), cardiac (ejection
fraction, CAD, inducible ischemia, previous MI, etc.) and lab
values.
Donor data—height, weight, sex, race, preservation
fluid/volume of flush (HTK/UW), pressors, hemodynamic
measures, date admission to hospital, date donation, cause of
death, donor following cardiac death technique, medical
history, recovery times and lab values (HbA1c, Amylase).
Intra-operative data—ASA, Mallampati, lines places, OR times,
fluids and transfusions, serial measures of MAP, glucose and
blood gases, revascularization times, arterial anastomotic site
(Y graft length), vein anastomotic site (vein graft used),
duodenal anastomotic site, reperfusion hemodynamic data,
immunosuppression, IVF volume infused prior to reperfusion,
mean intra-op blood glucose, side placed, and intra-op
occurrences.
Postoperative data—ICU admission, immunosuppression (drugs
used, mean levels, calcineurin delay/induction), reoperations,
endocrine (daily mean glucose), renal (dialysis, creatinine
trends), respiratory (pneumonia, etc.), infectious (locations and
organisms, sepsis, antibiotics), neurologic (stroke, delirium,
tacrolimus toxicity), cardiac (myocardial infarction, arrhythmia,
etc.), death within 30 days, technical graft loss, discharge
date, functional status trends.
Step 4. Establish a web-based data portal: The flow and
accuracy of data will be continually monitored and con-
tinuous database for data entry and retrieval would be
available. Center-specific data are always available to
members of the transplant team at that specific center.
This will significantly aid participating centers in inter-
nal quality assurance efforts. A web-based infrastruc-
ture for data management already exists with the ACS–
NSQIP and could be adapted to the transplant NSQIP.
Step 5. Issue reports: Periodically, a comprehensive report
will be released comparing the risk-adjusted surgical
outcomes of all participating centers in a blinded fash-
ion. The center will be able to compare its profile with
other institutions and national averages. Every effort will
be made to make the raw data available to affiliated and
non-affiliated researchers for analysis.
Step 6. Issue quality improvement action plans: The data
will then be used for quality improvement action plans.
Centers with outstanding improvements in care or out-
standing baseline care will be asked to share their “best
practice initiatives.” The majority of the resources of the
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program will eventually be devoted to dissemination of
specific systems of medical, surgical, anesthetic and
critical care that optimize quality transplant care. These
action plans offer a unique venue for a multidisciplinary
approach to complex transplant patients.
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